Ziel Partners with Portocanna to Receive the First EU GMP Certification for the Use of Frequency Technology for Microbial Control in Cannabis

May 16, 2024

SAN FRANCISCO, May 16, 2024 (GLOBE NEWSWIRE) -- Ziel, the industry leader providing next-generation customized, microbial control solutions for the agriculture and cannabis industries, today announced that its partner Portocanna, a medical cannabis processor in Portugal received GMP validation for the decontamination of cannabis flower using Ziel’s radio Frequency System (RF) technology. With the GMP certification in an EU member state, Portocanna is well positioned to supply medical cannabis from their EU-GMP pharmaceutical facility to the expanding markets in Germany and the UK.

“We are delighted that our radio frequency technology has received the first EU GMP approval for microbial control through our partnership with Portocanna,” says Arthur de Cordova, CEO and Co-Founder of Ziel. “We are well positioned in the EU to solve a problem every cultivator needs to address if they want to secure a presence in the rapidly growing European cannabis market.”

GMP defines the minimum standard that medical manufacturers must meet in their product processing operations under the European Medicines Agency (EMA), which coordinates and standardizes GMP activities at the European Union (EU) level. All entities that import or export cannabis to and within the EU are required to be GMP certified, representing a substantial investment and commitment to comply with these regulations. With this first GMP certification, Ziel’s technology now provides cultivators and post-harvest processors seeking to produce within the EU, or export to the EU, a clear, streamlined pathway for integrating a microbial control step into their operations.

Unlike ionizing forms of radiation such as X-ray, gamma, and e-beam, radio frequency is a non-ionizing, thermal process compliant with organic processes. In the European market, radio frequency does not require additional labeling and licensing for use in cannabis decontamination. For example, Germany requires registration of all strains treated with ionizing radiation (X-ray, gamma, and e-beam) prior to distribution within the country; a process that takes 6 to 9 months and an administrative fee of €2,500 per strain.

“Portocanna is extremely well positioned to increase medical cannabis exports from its EU GMP-certified facility,” said Amit Adri, CEO and founder of Portocanna S.A. “The use of radio frequency in our GMP processes allows us to efficiently meet increased demand following passage of Germany’s landmark cannabis reform law passed April 1, and efficiently meet strict German regulatory requirements for cannabis safety.”

“Domestically, Portocanna’s has received approval for one of its cannabis formulations on the Portuguese market,” continued Edri. “Our products are treated with radio frequency to meet Infarmed and EU requirements for patient safety.”

To learn more about Ziel or the RFX, please visit www.ziel.com.

About Ziel
Ziel is the industry leader providing next-generation customized, microbial control solutions for the agriculture and cannabis industries. The markets in which the company currently operates include tree nuts, seeds, and select fruit, as well as cannabis and hemp. Ziel’s products harness radio frequency and microwave technologies to build customized solutions that help customers consistently meet regulatory requirements, preserve product integrity, improve operational processes, and maximize profits. Ziel has a worldwide clientele who commercially process food and cannabis products with installations in the United States, Canada, Australia, Chile, Mexico, and across the EU. Ziel’s corporate headquarters are located in San Francisco. To learn more about Ziel’s solutions visit www.ziel.com.

About Portocanna
Portocanna aims to become the leading medical cannabis processor in Europe. With a 3,000 sqm EU GMP-certified facility, an in-house R&D lab, and the largest cannabis logistics center in the EU, the company is supported by a highly skilled and experienced team. After successfully launching medical cannabis products in Germany and the UK, and with a product soon to be introduced in the Portuguese market, Portocanna is focused on expanding its portfolio in these key markets. Additionally, the company is actively pursuing growth opportunities in other European regions. With 25 proprietary cannabis cultivars developed and registered, along with significant R&D investments, Portocanna is pioneering innovative delivery methods.

Media Contact:
Raquel Heras
Oak PR

Read the full article, linked here, on page 7.

Watch the full episode, here!

Highly Informed Podcast

In this episode, host Jon Purow interviews Arthur de Cordova, CEO of Ziel, about the company's microbial reduction technology for the cannabis industry. They explore Arthur's diverse background, the adaptation of Ziel's technology from textiles to cannabis, and the evolution of their business model. The conversation delves into regulatory challenges across states, the importance of microbial control in the supply chain for safety and compliance, and the financial risks of contamination. They also discuss market dynamics, such as oversupply and price compression, and look at the evolving European cannabis market.

Watch the full episode, here!

Cannabis Insider Interview

Join us as we engage with top-tier cannabis executives and investors, offering you an exclusive insider's glimpse into the cannabis industry. At Benzinga’s Cannabis Capital Conference, we explore the latest trends, strategies, and opportunities unfolding in the cannabis market. From invaluable investment insights to crucial regulatory updates and emerging market trends, trust us to keep you informed every step of the way. For the latest cannabis stories, visit www.Benzinga.com/cannabis.

Watch the full episode, here! 

Cannabis Radio Podcast

In this episode we welcome back Arthur de Cordova, CEO of Ziel, to discuss the company's presence in the German cannabis market. We explore the differences between the medical market in Europe and the recreational market in the United States, emphasizing the importance of quality and regulatory compliance. We also touch on the potential role of the FDA in safeguarding quality in the US cannabis industry. Arthur highlights Ziel's innovative microbial control solution and their sleek RFX machine.

Listen to the full episode, here! 

ICBC Barcelona

Europe Vs North America Panel Discussion

Watch the full panel discussion, here!


EXCLUSIVE: Is Germany Setting A New Cannabis Standard For Europe? Expert Weighs In.

Read how Ziel weighs in, here! 

Grow Magazine

Collectors Edition

Flip through the digital magazine, here! 

iGrow News

Written by Sepehr Achard

Read Sepehr Archard's full article on iGrow, here.

Key Takeaways:

  1. GMP Certification for Ziel’s RF Technology: Ziel receives the first EU GMP approval for microbial control in cannabis using Radio Frequency technology.
  2. Significance of GMP in the EU: GMP certification is a strict requirement for cannabis importers, producers, and exporters in the EU, reflecting a high standard of product processing.
  3. Advantages of Radio Frequency Over Ionizing Radiation: RF is a non-ionizing, organic-compliant process, avoiding additional labeling and lengthy registration processes required for ionizing radiation-treated cannabis.
  4. Strategic Positioning in the EU Cannabis Market: This certification positions Ziel to meet the growing demand for microbial control in the European cannabis industry.
  5. Innovative RFX Technology: The RFX, introduced in 2023, is highly efficient in cannabis processing, maintaining the unique properties of different strains.

Ziel’s Groundbreaking Radio Frequency Technology in Cannabis Microbial Control

Achieving GMP Certification in the EU

Ziel’s Radio Frequency (RF) technology has been recognized with Good Manufacturing Practice (GMP) certification for controlling microbial pathogens in cannabis flowers. This certification, under the European Medicines Agency (EMA), is crucial for all entities dealing with cannabis in the European Union (EU), indicating compliance with the highest standards in product processing.

Advantages of Radio Frequency Technology

RF technology, being non-ionizing, is compliant with organic processes and does not require the stringent additional labeling and licensing mandatory for ionizing radiation methods like X-ray, gamma, and e-beam. This makes RF a more streamlined and cost-effective option for cannabis decontamination in the EU, particularly in markets like Germany, which have lengthy and costly registration processes for ionizing radiation-treated cannabis.

Impact on the EU Cannabis Market

The GMP certification of Ziel’s RF technology marks a significant milestone for the company and the EU cannabis industry. This approval facilitates a clear pathway for cultivators and processors to integrate microbial control into their operations, which is crucial for participating in the rapidly growing European cannabis market.

The RFX: A New Solution in Cannabis Processing

Introduced at the MJBiz Conference in Las Vegas in 2023, Ziel’s next-generation cannabis microbial control solution, the RFX, boasts a high pass rate and industry-leading volume throughput. The technology is particularly suited for organic cannabis cultivation, preserving the unique enzymatic properties of different cannabis strains.

Collaboration and Design Excellence

The RFX represents a collaboration between Ziel and STALAM, a leading manufacturer of RF equipment. Its design, crafted by Ammunition Group under the leadership of former Apple industrial design director Robert Brunner, combines sleek aesthetics with functional excellence.

Unique Process and Benefits

Ziel’s proprietary process, patented for treating cannabis with RF technology, involves oscillating water molecules to generate consistent heat, effectively reducing microbial presence without compromising the quality of the cannabis flower. This process represents a significant innovation in treating agricultural products, including cannabis.